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ABSTRACT
Background: Studies of human papillomavirus (HPV)
awareness and HPV vaccine acceptability have included
few non-white participants, making it difficult to explore
ethnic differences. This study assessed HPV awareness
and HPV vaccine acceptability in a sample of women
representing the major UK ethnic minority groups.
Methods: A cross-sectional study design was used to
assess awareness of HPV and acceptability of HPV
vaccination. Participants were recruited using quota
sampling to ensure adequate representation of ethnic
minority women: Indian, Pakistani, Bangladeshi,
Caribbean, African and Chinese women (n = 750). A
comparison sample of white British women (n = 200)
was also recruited.
Results: Awareness of HPV was lower among ethnic
minority women than among white women (6–18% vs
39% in white women), and this was not explained by
generational status or language spoken at home. In a
subsample who were mothers (n = 601), ethnicity and
religion were strongly associated with acceptability of
HPV vaccination. Acceptability was highest among white
mothers (63%) and lowest among South Asians (11–
25%). Those from non-Christian religions were also less
accepting of the vaccine (17–34%). The most common
barriers to giving HPV vaccination were a need for more
information, sex-related concerns and concern about side-
effects. South Asian women were the most likely to cite
sex-related concerns, and were also least likely to believe
the vaccine would offer their daughters protection.
Conclusion: These findings suggest some cultural
barriers that could be addressed in tailored information
aimed at ethnic minority groups. They also highlight the
importance of recording ethnicity as part of HPV vaccine
uptake data.
The introduction of human papillomavirus (HPV)
vaccination aims to reduce the incidence of cervical
cancer. The three-dose vaccine is highly effective,
providing protection against HPV types 16 and 18,
which are responsible for approximately 70% of
cervical cancers.1 The UK programme offers vacci-
nation to girls aged 12–13 years. It is expected to
cost up to £100 m a year and, to maximise its
benefits, coverage must be high.2 This depends on
the vaccine being acceptable to parents.
In the UK, two large studies have explored
attitudes to HPV vaccination.3–5 The main barriers
have been concerns about vaccine side-effects and
the sexually transmitted nature of HPV infection,
which provokes worry that the vaccine will
promote sexual activity in adolescents. Similar
barriers have been identified around the world.6–11
In addition, work has shown very low awareness
of HPV as a risk factor for cervical cancer.12 13
To limit inequalities and support informed
choice, it is important to understand levels of
HPV awareness and HPV vaccine acceptability
across all sectors of the population. UK-based
studies have included relatively few non-white
participants, making it difficult to explore ethnic
differences. Some of the studies were designed to
be population representative, and so this was
expected from the outset.12 13 It also seems that
lower response rates occurred for ethnic minority
groups.3 4 Only one study has assessed vaccine
uptake in the UK, and it found lower levels in
schools with a higher proportion of pupils from
ethnic minority backgrounds.14
It is essential that uptake of the HPV vaccine is
equitable, or the immunisation programme could
widen ethnic disparities in health. A first step is
therefore to assess ethnic differences in accept-
ability of the vaccine, and to try to uncover the
reasons for any differences. We carried out a survey
recruiting participants from the major ethnic
minority groups in the UK, with the aims of
considering ethnic differences in awareness of HPV
and acceptability of HPV vaccination.
MATERIALS AND METHODS
Participants
Data were collected in two waves of the monthly
omnibus survey conducted by Ethnibus (July and
August 2008). Ethnibus (http://www.ethnicfocus.
com) recruits participants from the largest ethnic
minority groups in proportion to their representa-
tion in the UK population. Within each ethnic
group, quota-based age distributions are fulfilled.
The present sample had a total of 750 female
participants from six ethnic minority groups
(Indian, Pakistani, Bangladeshi, Caribbean,
African and Chinese) plus 200 white British
women.
Postal areas with high proportions of residents
from each ethnic group were randomly selected
using 2001 census data for England (mostly in
London and the Midlands). Multilingual inter-
viewers visited households in these areas, and
individuals, selected based on their self-reported
ethnicity, were invited to participate. Data were
collected during face-to-face interviews, and each
participant received a £5 incentive. Ethnibus
reported that approximately 70% of individuals
who met the eligibility criteria agreed to be
interviewed (based on figures recorded by the
interviewers), and this was similar to response
rates in other Ethnibus surveys. The research was
exempt from formal ethics committee approval
because it ensured complete anonymity.
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Measures
All participants were given HPV information based on the
Department of Health’s leaflet designed for girls aged 12–
13 years and their mothers. This was translated into the most
common languages (Urdu, Bangla, Hindi and Mandarin) by
agency-recruited qualified translators, translating into their first
language. For all the other languages (Punjabi, Gujarati, Somali,
Sylethi, Uroba, Lugani, Arabic, French and Portuguese), the
information was verbally translated during the interview.
Questions were developed from previous research and qualita-
tive interviews with 20 ethnic minority mothers.15 They
were then piloted with 45 women to ensure clarity. The
information provided and questions asked are available online as
Supplementary material.
After hearing the information, women were read the
following: ‘‘If you have a daughter age 12–13 years, please
think about her when answering the questions; if you don’t
have a daughter age 12–13 years, please imagine that you do.
Starting in September 2008, girls age 12–13 years (school year 8)
will be offered the HPV vaccination in school. If your daughter
were invited to have the HPV vaccination at school this
autumn, would you agree to her having it.’’ Responses were
made on a five-point scale (definitely not–yes definitely).
Women were asked to give a reason for their answer which
was recorded verbatim. All participants were asked to indicate
the father’s role in deciding about HPV vaccination because
qualitative work indicated possible ethnic differences in this.15
At the end of the interview, women were asked: ‘‘Before this
interview had you heard of HPV (human papillomavirus)’’, with
response options of yes, no and don’t know. This question was
asked at the end of the interview in order to avoid confusion
regarding similar terms (eg HIV) and to encourage women who
had heard of HPV but did not remember the name to say yes.
Socioeconomic class (SEC) was based on the occupation of
the chief earner in the household and was coded: AB manage-
rial/professional; C1 supervisory; C2 skilled manual; D semi-
skilled/unskilled manual; E state pensioners or casual/lowest
grade workers. These groupings are often used in market
research.16 Age group, marital status, religion and language
spoken at home were also assessed. An additional question
asked about generational status, classifying women as ‘‘second
generation’’ (UK-born and parents UK-born), ‘‘first generation’’
(UK-born but at least one parent non-UK-born) or ‘‘immigrant’’
(non-UK-born and parents non-UK-born). This question was
from the Millennium cohort study, a prospective study of
children in the UK.17 Generational status is an indicator of
acculturation and is an important issue when studying ethnic
minorities in the UK. It has been associated with maternal
health behaviours (eg breast-feeding), and we expected it to
influence the acceptability of HPV vaccination. For mothers
who are second generation, both they and their parents were
born, brought up and educated in Britain, and they would
therefore be expected to have more westernised attitudes.
Finally, women indicated whether they had any daughters and
what ages they were.
Analysis
Data were analysed using SPSS 15.0. HPV awareness and HPV
vaccine acceptability were recoded into binary variables.
Women responding to the HPV awareness question were
categorised as ‘‘aware of HPV’’ (yes) or ‘‘not aware of HPV’’
(no/don’t know). Mothers responding to the HPV vaccine
acceptability question were coded as ‘‘acceptors’’ (yes probably/
yes definitely) or ‘‘non-acceptors’’ (probably not/definitely not/
unsure). Initially, mothers who were ‘‘unsure’’ were considered
as a separate group but, as they were not distinctly different
from those who said probably or definitely not, the two groups
were combined. Univariate logistic regression analyses were run
to identify predictors of HPV awareness and vaccine accept-
ability. Significant univariate predictors were entered into a
multivariate model.
A coding frame was developed (by LM) and applied (by LM
and AF) to the mothers’ verbatim reasons for their decision.
Inter-rater reliability was ‘‘outstanding’’ (kappa = 0.94). x2
analyses were used to explore reasons for the vaccine decision
(cited vs not cited) and involvement of the father (mother takes
lead, father takes lead, decide together). For each analysis,
different ethnic groups were compared with the white group.
RESULTS
Sample characteristics
The sample included 950 women: white British (n = 200),
Indian (n = 235), Pakistani (n = 164), Bangladeshi (n = 63),
Caribbean (n = 130), African (n = 107) and Chinese (n = 51).
Sample characteristics are shown in table 1. Most women were
aged 25–34 years (26%) or 35–44 years (28%), were married
(66%) and were in socioeconomic classes C or D (supervisory,
24%; or manual workers, 49%). Most women reported some
religious affiliation (87%), with the majority being Christian
(30%) or Muslim (36%). There were roughly equal proportions
of ‘‘second generation’’, ‘‘first generation’’ and ‘‘immigrants’’
among Indian, Caribbean, African and Chinese women. There
were fewer second-generation Pakistanis and Bangladeshis (15%
and 6% respectively). Most respondents spoke English at home
(68%), but this varied by ethnicity and generational status.
Awareness of HPV
Overall, 17% of women reported (at the end of the interview)
that they had heard of HPV before taking part in the study.
Univariate logistic regression explored predictors of HPV
awareness; odds ratios (ORs) and confidence intervals (CIs)
are shown in table 2. There was no association between SEC
and awareness of HPV, but there was a slight difference by age,
with higher awareness in women aged 16–24 years than in
women aged 35–44 years (22% vs 13%). There was also a
difference in relation to marital status, with higher awareness in
single than in married women (21% vs 14%). There was wide
variation across ethnic groups, with 39% of white British
women having heard of HPV, but much lower awareness in all
ethnic minority groups: Chinese (18%), Caribbean (14%),
Pakistani (12%), Indian (9%), African (8%) and Bangladeshi
(6%). Religion, generational status and language spoken at
home were also predictors of awareness in univariate analyses.
Fewer Muslim (10%) and more Christian women (27%) were
aware of HPV than women with no religion (18%). There was
greater awareness among ‘‘second-generation’’ women (24%)
than ‘‘first-generation’’ (14%) or ‘‘immigrant’’ women (10%),
and women who spoke English at home were more likely to
have heard of HPV (19%) than those who spoke another
language (11%). In multivariate logistic regression, age,
ethnicity and religion remained significant (overall model:
x2(18) = 123.76, p,0.001; Nagelkerke R2 = 0.21). Marital status,
language and generation were no longer significant.
HPV vaccine acceptability
Just under half the sample (n = 440) had a daughter under
16 years old and, of these, 137 had a daughter aged 12–13 years.
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An additional 17% (n = 161) had a daughter aged 16 years or
older. Acceptability did not differ based on the daughter’s age,
so all women with a daughter, regardless of her age, were
included in the analysis of acceptability (n = 601). Overall, 38%
of mothers were ‘‘acceptors’’ (21% yes definitely; 17% yes
probably) and 62% were ‘‘non-acceptors’’ (18% probably not;
19% definitely not; 25% ‘‘unsure’’). Univariate logistic regres-
sion explored predictors of HPV vaccine acceptability (ORs and
CIs are shown in table 2). There were no associations between
HPV vaccine acceptability and age, marital status or SEC.
Acceptability varied by ethnic group, being highest in white
women (63%) followed by African, Caribbean and Chinese
women (51%, 49% and 40%), and much lower among Indian,
Bangladeshi and Pakistani women (25%, 18% and 11%).
Acceptability also varied on the basis of generational status
and whether English was spoken at home. It was higher in
‘‘second-generation’’ (50%) than ‘‘first-generation’’ migrants
(35%) and ‘‘immigrants’’ (25%), and among mothers who spoke
English at home (44%) than among those who spoke another
language (26%). Religion was associated with acceptability,
with fewer ‘‘acceptors’’ among Hindus (34%) and Muslims
(18%) compared with those with no religion (64%). In multi-
variate analyses, which included SEC, only ethnicity and
religion remained significant (overall model: x2(13) = 129.14,
p,0.001; Nagelkerke R2 = 0.26).
Reasons for intended vaccine decision
Table 3 shows the reasons that mothers cited for their intended
vaccine decision. The most common reasons for giving the
vaccine were: the protection it would offer from ‘‘HPV’’ or
‘‘cervical cancer’’, health reasons, for example for their
daughter’s ‘‘health’’, ‘‘safety’’ or ‘‘well-being’’, and because of
a general positive response to the vaccine, for example ‘‘I feel
positive about it’’. Other reasons included ‘‘peace of mind’’,
‘‘because there is a need for it’’, ‘‘because it will be made freely
available’’ and ‘‘because it is part of a parent’s responsibility’’.
The most common reasons for declining were: needing more
information (either about ‘‘side-effects’’ or generally), sex-
related concerns (eg ‘‘it encourages promiscuity’’ or ‘‘risk of
premature sex’’), religious/cultural reasons (eg ‘‘we’re very
religious, no sex before marriage’’) and concerns about safety.
Other reasons not to give the vaccination included believing it
Table 1 Sample characteristics for women in each ethnic group (column percentages)
White
(n = 200)
Indian
(n = 235)
Pakistani
(n = 164)
Bangladeshi
(n = 63)
Caribbean
(n = 130)
African
(n = 107)
Chinese
(n = 51)
Age (years)
16–24 10 20* 23* 29* 22* 20* 24*
25–34 29 29 24 24 24 30 18
35–44 25 26 34 25 22 35 43*
45–54 17 12 10 16 15 9 16
55+ 21 15 10* 6* 17 7* 0*
Marital status
Married/cohabitating 73 63* 71 78 52* 62 71
Single 21 25 25 8* 42* 34* 22
Divorced/separated/widowed 7 12 4 14 5 5 8
Socioeconomic class
AB Managerial/professional 15 18 7* 21 7 6* 8
C1 Supervisory 18 27* 28* 21 22 22 28
C2 Skilled manual 29 27 35 30 29 19 31
D Semi-skilled/unskilled manual 22 16 14 18 28 29 14
E State pensioners/unemployed 17 12 15 11 15 24 20
Religion
Christian 64 9* 0.0* 0* 76* 36* 8*
Hindu 0 56 0 0 0 0 0
Sikh 0 17 0 0 0 0 0
Muslim 0 18 100 100 0 64 0
Other 4 0 0 0 0 0 35
None 33 0 0 0 24 1 53
Language
English 100 57* 51* 67* 100 38* 27.5*
Punjabi 0 17 13 0 0 0 0
Hindi 0 9 0 0 0 0 0
Gujarati 0 13 0 0 0 0 0
Urdu 0 5 36 0 0 0 0
Bangla 0 0 0 22 0 0 0
Mandarin 0 0 0 0 0 0 73
Somali 0 0 0 0 0 49 0
Other 0 0 0 11 0 13 0
Generational status
Second generation 94 26* 15* 6* 35* 24* 28*
First generation 6 32 54 48 29 36 33
Immigrant 0 43 32 46 35 40 39
Bold type represents when a 262 x2 was used to analyse the difference in that ethnic group compared with the white British group. Where figures are not in bold type, it was not
possible to compute x2 results because more than 20% of cells in the analysis had a count of less than 5.
*p,0.05.
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would be unnecessary or inappropriate, age-related reasons (eg
12–13 years is too young), lack of trust in vaccinations and
wanting to discuss the decision with other family members.
We explored whether some ethnic groups were more or less
likely to cite specific reasons for their decision. Citing the
‘‘protection’’ that the vaccine would offer occurred less among
Indian (16%), Pakistani (11%), Bangladeshi (13%) and
Caribbean mothers (14%) compared with white mothers
(29%), but there were no differences between white and
African or Chinese mothers. Needing more information was
cited more by Bangladeshi mothers than by white mothers (44%
compared with 16%), but there were no differences between
white mothers and mothers from any other backgrounds. We
were able to look at differences for Indian and Pakistani mothers
in citing sex-related reasons, religious reasons, daughter’s health
and future benefits. Sex-related reasons were more likely to be
cited by both Indian (15%) and Pakistani mothers (20%) than
white British mothers (2%). None of the other reasons differed
significantly. Limited numbers meant that differences could not
be explored for Bangladeshi, Caribbean, African and Chinese
women (more than 20% of cells in the x2 analyses had an
expected count of less than 5).
The role of fathers in deciding about HPV vaccination
Table 4 shows the mothers’ responses to the question about
fathers’ involvement in the decision to vaccinate against HPV.
Overall, 41% of mothers said they would take the lead in
deciding about HPV vaccination, and 52% said they would
make a joint decision with the father. Again, this varied by
ethnic group, with a shared decision most likely in Indian
(61%), Pakistani (57%), Bangladeshi (66%), African (63%) and
Caribbean groups (56%) and least likely in Chinese (30%) and
white groups (36%). In comparison with white British mothers,
all ethnic minorities except the Chinese were more likely to
share the decision. A small proportion (7%) said the father
would take the lead role in deciding about HPV vaccination, and
this was slightly more common among Chinese (17%),
Bangladeshi (16%), Pakistani (10%) and Indian (9%), followed
Table 2 Univariate logistic regression analyses exploring predictors of HPV awareness (n = 950) and acceptability of HPV vaccination (mothers only,
n = 601)
Awareness of HPV Acceptability of HPV vaccination
% OR (95% CI) p Value % OR (95% CI) p Value
Ethnicity
White British 39 1.00 63 1.00
Indian 9 0.15 (0.09 to 0.26) ,0.001 25 0.20 (0.12 to 0.33) ,0.001
Pakistani 12 0.22 (0.13 to 0.38) ,0.001 11 0.07 (0.04 to 0.14) ,0.001
Bangladeshi 6 0.11 (0.04 to 0.30) ,0.001 18 0.13 (0.06 to 0.29) ,0.001
Caribbean 14 0.25 (0.14 to 0.45) ,0.001 49 0.55 (0.32 to 0.98) 0.040
African 8 0.13 (0.08 to 0.27) ,0.001 51 0.61 (0.33 to 1.10) 0.102
Chinese 18 0.34 (0.16 to 0.73) 0.006 40 0.39 (0.18 to 0.87) 0.022
Age (years)
16–24 22 1.78 (1.08 to 2.93) 0.024 17 0.38 (0.14 to 1.02) 0.054
25–34 18 1.42 (0.88 to 2.30) 0.149 43 1.43 (0.94 to 2.16) 0.091
35–44 13 1.00 35 1.00
45–54 19 1.55 (0.88 to 2.74) 0.128 36 1.06 (0.63 to 1.77) 0.834
55+ 11 0.81 (0.42 to 1.56) 0.527 43 1.42 (0.87 to 2.32) 0.167
Marital status
Married/cohabitating 14 1.00 37 1.00
Single 21 1.60 (1.09 to 2.33) 0.015 36 0.95 (0.55 to 1.65) 0.848
Divorced/separated/widowed 23 1.65 (0.91 to 3.00) 0.099 43 1.24 (0.68 to 2.28) 0.480
Socioeconomic class
AB Managerial/professional 21 1.00 38 1.00
C1 Supervisory 17 0.78 (0.44 to 1.38) 0.400 34 0.81 (0.46 to 1.43) 0.471
C2 Skilled manual workers 16 0.74 (0.43 to 1.29) 0.293 34 0.83 (0.48 to 1.42) 0.486
D Semi-skilled/unskilled manual workers 15 0.67 (0.37 to 1.22) 0.187 38 0.98 (0.55 to 1.73) 0.935
E State pensioners/unemployed 16 0.73 (0.39 to 1.37) 0.325 48 1.48 (0.83 to 2.66) 0.187
Religion
None 18 1.00 64 1.00
Christian 27 1.73 (1.02 to 2.93) 0.043 53 0.61 (0.37 to 1.03) 0.066
Hindu 12 0.61 (0.30 to 1.24) 0.173 34 0.28 (0.15 to 0.53) ,0.001
Muslim 10 0.51 (0.23 to 0.92) 0.024 18 0.12 (0.07 to 0.21) ,0.001
Other 16 0.93 (0.42 to 2.05) 0.855 17 0.12 (0.04 to 0.33) ,0.001
Language
English 19 1.00 44 1.00
Not English 11 0.52 (0.35 to 0.79) 0.002 26 0.45 (0.31 to 0.65) ,0.001
Generational status
Second generation 24 1.00 50 1.00
First generation 14 0.51 (0.34 to 0.76) 0.001 35 0.54 (0.36 to 0.80) 0.002
Immigrant 10 0.37 (0.23 to 0.57) ,0.001 25 0.34 (0.22 to 0.51) ,0.001
Aware of HPV
Yes – – – 41 1.00
No – – – 37 0.83 (0.52 to 1.32) 0.432
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by African (5%) and Caribbean mothers (3%). None of the white
mothers said the father would take the lead role in the decision
(x2 results are not reported for this finding because more than
20% of cells in the analysis had a count of less than 5).
DISCUSSION
Acceptability of HPV vaccination for a 12- to 13-year-old
daughter was much lower in ethnic minority mothers than in
white mothers, with the lowest levels among mothers from
South Asian backgrounds. This was the case even after
controlling for SEC. This suggests that previous research with
predominantly white British parents cannot be extrapolated to
ethnic minority parents, emphasising the importance of
including minority women in future research. If these findings
map on to uptake, it may mean that some areas of the UK
achieve particularly low uptake. The non-white population
accounts for 8% across Britain, but this rises to 30% in some
areas (Slough, Leicester, Luton, Birmingham and London), and is
even greater in parts of London (eg Brent, 71%; Newham,
66%).18 To date, collection of ethnicity data by the NHS has
been limited, but this is expected to improve,19 and the parental
consent form for HPV vaccination in England includes a box to
record ethnicity. These findings support the importance of
monitoring ethnicity in relation to uptake of the HPV
vaccination.
Generation and language spoken at home were not significant
predictors of acceptability in multivariate analyses, suggesting
that acculturation does not mediate the effect of ethnicity.
However, religion remained an important factor, and ‘‘religious
reasons’’ were one of the main reasons cited for declining the
vaccine. This is consistent with previous work that found
parents with ‘‘strong religious or cultural views’’ were less likely
to accept HPV vaccination.3 It is also consistent with attitudes
to HPV testing, which some minority women felt reflected
‘‘non-traditional cultural or religious practices concerning sex
and monogamy’’.20 The importance of religion appears to come
from a strong belief in sexual abstinence until marriage, and this
is a barrier that will be a challenge to overcome. There is
evidence that South Asian women have fewer sexual partners
than white women; nonetheless, 13–29% report more than one
lifetime sexual partner, and this is nearly 50% in South Asian
men.21 Liaising with religious groups about the best ways to
communicate HPV information may help to make HPV
vaccination more acceptable.
Across the board, one of the most common barriers to
accepting HPV vaccination was concern about side-effects. This
is consistent with a recent study of HPV vaccine uptake,14 and
was important to all mothers regardless of ethnicity. An
additional reason given ‘‘against’’ HPV vaccination was the
belief that the vaccine would ‘‘lead to early sex’’ or ‘‘encourage
promiscuity’’, which again has been suggested as a reason for
non-acceptability in numerous other studies.3 4 6 8 10 11 This
concern was cited more by South Asian women.
We decided to ask about awareness of HPV at the end of the
interview, so that women knew what HPV was before saying
whether they had heard of it. This makes it unlikely that levels
of awareness are underestimated in this study, and means that
the findings may not be comparable to other studies which have
Table 3 Reasons for HPV vaccine decision (percentage of mothers citing each reason, n = 601)
White
(n = 149)
Indian
(n = 130)
Pakistani
(n = 112)
Bangladeshi
(n = 45)
Caribbean
(n = 74)
African
(n = 61)
Chinese
(n = 30)
Reasons for accepting
Protection 29 16* 11* 13* 14* 25 30
Daughter’s health 9 6 5 2 16 7 7
General positive beliefs 5 2 3 0 7 7 0
Benefits 5 3 5 0 3 7 0
Availability 3 1 0 0 3 0 3
There is a necessity 2 1 1 0 1 0 0
Responsibility 3 0 0 0 1 0 0
Peace of mind 0 0 1 0 3 2 0
Reasons for not accepting
More information needed 16 12 21 44* 18 10 20
Sex-related reasons 2 15* 20* 4 16 5 10
Safety/side-effects 7 12 6 13 5 5 3
Religion/culture 5 8 6 0 3 7 3
No necessity 0 8 5 2 0 2 0
Age-related reasons 1 2 1 4 1 3 0
Trust 0 2 5 0 0 2 0
Discuss with family 1 2 1 0 0 2 0
Bold type represents when a 262 x2 was used to analyse the difference in that ethnic group compared with the white British group. Where figures are not in bold type, it was not
possible to compute x2 results because more than 20% of cells in the analysis had a count of less than 5.
* p,0.05.
Table 4 Fathers’ roles (column percentages)
White
(n = 149)
Indian
(n = 130)
Pakistani
(n = 112)
Bangladeshi
(n = 45)
Caribbean
(n = 74)
African
(n = 61)
Chinese
(n = 30)
I would take the lead role 64 31* 32* 18* 42* 32* 53
We would decide together (50:50) 36 61* 57* 66* 56* 63* 30
Her father would take the lead role 0 9 10 16 3 5 17
Bold type represents when a 262 x2 was used to analyse whether the reason was cited more/less in that ethnic group compared with the white British group.
*Indicates a significant difference, p,0.05.
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assessed it at the beginning of the interview. Ethnicity was
associated with HPV awareness, with much lower levels in all
the ethnic minority women, particularly Indian, African and
Bangladeshi women (,10%). Interestingly, language spoken at
home did not explain this effect, suggesting that it is not purely
the result of a language barrier. One alternative explanation
could be variation in exposure to publicity about HPV because
of lower coverage in culturally specific media or because sex-
related topics are considered ‘‘taboo’’ and as a consequence are
discussed less in some cultures. Given that knowledge of HPV is
necessary for informed decision-making about vaccination,
tailoring information campaigns and channelling these through
media outlets aimed at specific ethnic groups may help to raise
awareness.
One additional finding of interest was that ethnic minority
mothers were more likely to believe the father would play an
important role in the decision to vaccinate against HPV. To
date, there has been little research into fathers’ attitudes in the
UK, and the Department of Health leaflet about HPV has been
aimed at girls and their mothers. Future research exploring
parental decision-making with regard to HPV vaccination
among ethnic minorities should include fathers.
There are several limitations to this study. The sampling
method means the findings may not be generalisable to all
ethnic minority mothers in the population, although the quota
sampling technique allowed us to focus on and compare ethnic
minority groups. The response rate of 70% was good; however,
the figure is based on details recorded by the field interviewers.
As the interviewers sometimes forget to report these response
details, Ethnibus describe the response rate as ‘‘approximate’’
rather than exact. The response rate should therefore be
interpreted with caution. Another issue is that, although all
mothers in the acceptability analysis had a daughter, not all
daughters were aged 12–13 years, and this meant that some
mothers were responding hypothetically. Third, we did not
assess actual vaccine uptake, and statements about intention
can only be indicative of acceptance of HPV vaccination.
Expected vaccine acceptance in this sample of white mothers
was 63%, which was lower than the 75% and 81% that have
been found in other studies.3 4 However, in previous surveys,
parents were asked to return a questionnaire about vaccination,
and thus these studies may have received responses only from
the most ‘‘motivated’’ parents, whereas in the present study,
the questions formed part of a larger survey on a range of issues, so
attitudes to this topic are unlikely to have biased participation.
Over the coming years, it will be possible to incorporate
behavioural outcomes into work on HPV attitudes, but for now
exploring acceptability offers some insight into a decision that is
facing parents of adolescent girls right now. It gives a head start
in understanding possible inequalities before uptake data from
the first cohorts of girls are available. Understanding ethnic
differences in acceptability of HPV vaccination will be
particularly useful to health promotion specialists working in
ethnically dense areas of the country, helping them to limit
inequalities and support informed choice by all.
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What is already known on this subject
c HPV vaccination is now offered to all girls aged 12–13 years.
c In one study, uptake was lower in schools with a higher
proportion of ethnic minority pupils.
c One criticism of the UK-based studies is their limited inclusion
of non-white participants.
What this study adds
c Ethnicity and religion are predictors of HPV awareness and
acceptability of HPV vaccination.
c Sex-related concerns are more likely to be a barrier among
ethnic minority parents.
c The ethnic differences found in this study support the
importance of monitoring ethnicity in vaccine uptake data.
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